Nilotinib therapy in chronic myelogenous leukemia: the strength of high selectivity on BCR/ABL.
about
Nilotinib therapy in chronic myelogenous leukemia: the strength of high selectivity on BCR/ABL.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Nilotinib therapy in chronic m ...... f high selectivity on BCR/ABL.
@en
Nilotinib therapy in chronic m ...... f high selectivity on BCR/ABL.
@nl
type
label
Nilotinib therapy in chronic m ...... f high selectivity on BCR/ABL.
@en
Nilotinib therapy in chronic m ...... f high selectivity on BCR/ABL.
@nl
prefLabel
Nilotinib therapy in chronic m ...... f high selectivity on BCR/ABL.
@en
Nilotinib therapy in chronic m ...... f high selectivity on BCR/ABL.
@nl
P1433
P1476
Nilotinib therapy in chronic m ...... f high selectivity on BCR/ABL.
@en
P304
P356
10.2174/138945009788488468
P577
2009-06-01T00:00:00Z